Farallon Capital Management LLC Gossamer Bio, Inc. Transaction History

Farallon Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.48 - $1.08 $2.94 Million - $6.62 Million	6,130,272 New	6,130,272 $5.58 Million
Q3 2023 Nov 14, 2023	BUY	$0.78 - $1.82 $4.78 Million - $11.2 Million	6,130,272 New	6,130,272 $5.09 Million
Q2 2021 Aug 13, 2021	BUY	$8.0 - $9.75 $818,608 - $997,678	102,326 Added 102.33%	202,326 $1.64 Million
Q1 2020 May 15, 2020	SELL	$8.0 - $15.48 $3.2 Million - $6.19 Million	-400,000 Reduced 80.0%	100,000 $1.02 Million
Q4 2019 Feb 13, 2020	BUY	$14.82 - $26.79 $5.92 Million - $10.7 Million	399,288 Added 396.47%	500,000 $7.82 Million
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $11,406 - $15,998	712 Added 0.71%	100,712 $1.69 Million
Q2 2019 Aug 14, 2019	SELL	$16.12 - $22.89 $4.48 Million - $6.36 Million	-277,852 Reduced 73.53%	100,000 $2.22 Million
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $6.64 Million - $9.06 Million	377,852 New	377,852 $8.19 Million

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.